| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/16/2011 | US20110142902 Hypoxia Inducing Factor (HIF) Stabilising Glasses |
| 06/16/2011 | US20110142895 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142881 Transcutaneous delivery of therapeutic agents |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 06/16/2011 | US20110142877 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents |
| 06/16/2011 | US20110142873 Bioactive purified hspe7 compositions |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142870 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 06/16/2011 | US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 06/16/2011 | US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/16/2011 | US20110142857 Methods of altering peripheral b cell populations and uses thereof |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142855 Compounds Having CRTH2 Antagonist Activity |
| 06/16/2011 | US20110142854 Compositions and methods for inhibition of retroviruses |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142831 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
| 06/16/2011 | US20110142797 Method For Prophylaxis or Treatment of Feline Infectious Peritonitis |
| 06/16/2011 | US20110142792 Compositions for Increasing Polypeptide Stability and Activity, and Related Methods |
| 06/16/2011 | US20110142769 Low toxicity topical active agent delivery system |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
| 06/16/2011 | US20110139152 Antibiotic microparticles for inhalation |
| 06/16/2011 | CA2820202A1 Method of reversing immune suppression of langerhans cells |
| 06/16/2011 | CA2783962A1 Method for late introduction of the (8r)-hydroxyl group in carbapenem .beta.-lactam antibiotic synthesis |
| 06/16/2011 | CA2783929A1 5-amino-4-hydroxypentoyl amides |
| 06/16/2011 | CA2783612A1 Composition for treating skin lesions |
| 06/16/2011 | CA2783540A1 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications |
| 06/16/2011 | CA2782898A1 Novel cyclic peptides |
| 06/16/2011 | CA2782789A1 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | CA2782624A1 Therapeutic use of protein-polymer conjugates |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333114A1 S. pneumoniae antigens |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332952A1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
| 06/15/2011 | EP2332938A1 Viral inhibitors |
| 06/15/2011 | EP2332925A1 Novel dihydrotriazine derivative |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332904A2 Derivatives of tetracycline compounds |
| 06/15/2011 | EP2332581A1 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332563A2 Use of BAFF to treat sepsis |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332554A1 Anti-viral agent |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
| 06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332544A1 New pharmaceutical composition suitable for treating persons affected by human immunodeficiency virus (HIV) |
| 06/15/2011 | EP2332538A1 Combinations comprising a 4-isoquinolone derivative and anti-HIV agents |
| 06/15/2011 | EP2332532A1 New multi-therapy administration patterns suitable for treating persons affected by human immunodeficiency virus (HIV) |
| 06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 06/15/2011 | EP2331687A2 Antimicrobial agents |
| 06/15/2011 | EP2331581A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments |
| 06/15/2011 | EP2331580A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 06/15/2011 | EP2331574A2 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/15/2011 | EP2331564A2 Methods of treating inflammation |
| 06/15/2011 | EP2331554A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 06/15/2011 | EP2331552A1 Hepatitis c virus inhibitors |
| 06/15/2011 | EP2331538A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor |
| 06/15/2011 | EP2331529A2 Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof |
| 06/15/2011 | EP2331526A2 Pyrimidine derivatives as kinase inhibitors |
| 06/15/2011 | EP2331497A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 06/15/2011 | EP2331133A2 Anti-lipid antibodies |
| 06/15/2011 | EP2331128A1 Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 06/15/2011 | EP2331122A2 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 06/15/2011 | EP2331117A1 Vaccines containing canine parvovirus genetic variants |
| 06/15/2011 | EP2331116A1 Anti-infective compounds and uses thereof |
| 06/15/2011 | EP2331110A1 Compositions and methods for engineering probiotic yeast |
| 06/15/2011 | EP2331104A2 Method of inducing an anti-viral immune response |
| 06/15/2011 | EP2331048A1 Oligomeric biosurfactants in dermatocosmetic compositions |
| 06/15/2011 | EP2203430B1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 06/15/2011 | EP2097434B1 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 06/15/2011 | EP1771454B1 Hepatitis c inhibitor peptide analogs |
| 06/15/2011 | EP1766093B1 Antibodies against clostridium difficile toxins and uses thereof |
| 06/15/2011 | EP1455809B1 Inhibitors of hepatitis c virus |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 06/15/2011 | CN1995056B Curcumenol glucoside compound and its preparation method and uses |
| 06/15/2011 | CN1985842B Oral azithromycin resin suspension and its preparing method |
| 06/15/2011 | CN1969874B Externally applied pharmaceutical composition of abafungin |
| 06/15/2011 | CN1943647B The method for preparing triterpenic acid extract from the loquat leaves |
| 06/15/2011 | CN1942578B Low virulent strain of recombinant newcastle disease lasota vaccine expressing HA protein of avian influenza-H5 virus |
| 06/15/2011 | CN1939380B Heat-clearing analgesic medicinal composition with anti-infective and antiviral functions |
| 06/15/2011 | CN1847256B Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin |
| 06/15/2011 | CN1814176B Chinese medicinal composition for treating tuberculosis and its preparation method |
| 06/15/2011 | CN1780907B Anti-CCR5 antibody |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099473A Novel therapeutic agents against hepatitis |
| 06/15/2011 | CN102099378A Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same |